In conclusion, although the elucidation of the molecular mechanisms that cause the metabolic alterations of GSD1a in renal cells deserves further studies, the evidence of a disease-specific response of GSD1a URECs to a metabolic (low glucose) stimulus suggests that this cell model can be a promising tool for dissecting GSD1a nephropathy. Here, G6PC1 is linked to kidney disorder.